Vicarious Surgical (RBOT) Cash from Operations (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash from Operations came in at 10464000.0 in Q3 2025, up 17.53% year-on-year from 8902889.63 in Q3 2024, and up 22.67% on a QoQ basis from 13532000.0 in Q2 2025.
Vicarious Surgical (RBOT) Cash from Operations (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Cash from Operations data on file, last reported at 10464000.0 in Q3 2025.
- On a quarterly basis, Cash from Operations rose 17.53% year-over-year to 10464000.0 in Q3 2025; TTM through Sep 2025 was 47552000.0, a 4.01% increase from a year earlier, with the FY2024 full-year figure at 49956000.0, up 19.82% from the prior year.
- Cash from Operations for Q3 2025 stood at 10464000.0, up from 13532000.0 in the prior quarter.
- Over the last five years, Cash from Operations for RBOT reached as high as 4140000.0 in Q1 2021 and fell as low as 18570000.0 in Q1 2023.
- Historically, Cash from Operations has averaged 12764947.37 across 5 years, with a median of 13532000.0 in 2025.
- Across the five-year window, Cash from Operations plunged 3822.41% in 2021 and soared 38.24% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 9753000.0 in 2021, then sank by 88.75% to 18409000.0 in 2022, then soared by 38.24% to 11370000.0 in 2023, then dropped by 3.68% to 11788000.0 in 2024, then gained by 11.23% to 10464000.0 in 2025.
- Per Business Quant data, the three most recent Cash from Operations figures were 10464000.0 in Q3 2025, 13532000.0 in Q2 2025, and 11768000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.46 Mn |
| Sep 30, 2025 | -10.46 Mn |
| Jun 30, 2025 | -13.53 Mn |
| Jun 30, 2025 | -13.53 Mn |
| Mar 31, 2025 | -11.77 Mn |
| Mar 31, 2025 | -11.77 Mn |
| Dec 31, 2024 | -11.79 Mn |
| Dec 31, 2024 | -11.79 Mn |
| Sep 30, 2024 | -12.69 Mn |
| Sep 30, 2024 | -12.69 Mn |
| Jun 30, 2024 | -11.02 Mn |
| Jun 30, 2024 | -11.02 Mn |
| Mar 31, 2024 | -14.46 Mn |
| Mar 31, 2024 | -14.46 Mn |
| Dec 31, 2023 | -11.37 Mn |
| Dec 31, 2023 | -11.37 Mn |
| Sep 30, 2023 | -17.28 Mn |
| Sep 30, 2023 | -17.28 Mn |
| Jun 30, 2023 | -15.08 Mn |
| Jun 30, 2023 | -15.08 Mn |